Doug Schenkel analyst UBS

Currently out of the existing stock ratings of Doug Schenkel, 68 are a HOLD (31.34%), 148 are a BUY (68.2%), 1 are a SELL (0.46%).

Doug Schenkel

Work Performance Price Targets & Ratings Chart

Analyst Doug Schenkel, currently employed at UBS, has had 84.75% of price targets met with an average potential upside of 29.13%, reached in 243 days on average. Previously, Doug Schenkel worked at TD COWEN, COWEN, WOLFE.

Doug Schenkel has documented 414 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.

Most recent stock forecast was given on CAI, CAI International at 09-Sep-2026.

Wall Street Analyst Doug Schenkel

Analyst best performing recommendations are on CAI (CAI INTERNATIONAL).
The best stock recommendation documented was for GH (GUARDANT HEALTH) on 10/29/2018. The price target of $40 was fulfilled within 4 days with a profit of $7.41 (22.74%), with a performance score of 56.84.

Average potential price target upside

AMRS Amyris DHR Danaher DXCM DexCom FLDM Fluidigm GH Guardant Health GNMK GenMark Diagnostics HOLX Hologic ILMN Illumina MYGN Myriad Genetics NVTA Invitae Corp PACB Pacific Biosciences of California TMO Thermo Fisher Scientific TNDM Tandem Diabetes Care WAT Waters ZY Zymergen A Agilent Technologies EXAS EXACT Sciences NTRA Natera QGEN Qiagen NV NSTG NanoString Technologies AVTR Avantor PKI PerkinElmer PODD Insulet TWST Twist Bioscience Corp TXG 10X Genomics XGN Exagen BRKR Bruker CDXS Codexis GHDX Genomic Health LAB Standard Biotools RGEN Repligen AA Alcoa Corp AMR Alpha Metallurgical Resources NVT nVent Electric PLC OXFD Oxford Immunotec Global PLC CAI CAI International RVTY Revvity TEM Tempus AI VCYT Veracyte BDX Becton Dickinson and Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$0.65

$0.51 (364.29%)

$3.35

3 years 5 months 28 days ago
(18-May-2023)

2/2 (100%)

$0.06 (10.17%)

10

Buy

$1.25

$1.2 (2400.00%)

$19

3 years 6 months 5 days ago
(10-May-2023)

3/4 (75%)

$2.13 (47.39%)

21

Buy

$5

$4.86 (3471.43%)

$30

3 years 7 months 30 days ago
(16-Mar-2023)

7/10 (70%)

$3.68 (278.79%)

819

Hold

$2

$1.86 (1328.57%)

$2.5

3 years 10 months 12 days ago
(03-Jan-2023)

1/2 (50%)

$0.55 (37.93%)

2

Hold

4 years 6 days ago
(09-Nov-2022)

1/2 (50%)

$7.57 (43.43%)

391

Show more analysts

Please expand the browser size to see the chart

Which stock is Doug Schenkel most bullish on?

Potential upside of $115.91 has been obtained for NTRA (NATERA)

Which stock is Doug Schenkel most reserved on?

Potential downside of -$14.39 has been obtained for RVTY (REVVITY)

What Year was the first public recommendation made by Doug Schenkel?

On 2013
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?